MedPath

Matrix metalloproteinase 9 variation in erosive oral lichen planus before and after treatment

Phase 2
Conditions
erosive oral lichen planus.
Other lichen planus
Registration Number
IRCT2016071728963N1
Lead Sponsor
Vice Chancellor for research of Shahid Beheshti University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Patients with erosive oral lichen planus with clinical and pathological confirmation whom need treatment. Exclusion criteria: Cutaneous lichen planus; Drug lichenoid reaction; Contact lichenoid reaction.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Matrix metalloproteinase 9. Timepoint: before and after treatment. Method of measurement: ELIASA technique.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath